The Psychedelics Year in Review (2021)
Psychedelics developments in 2021 covered everything from legalization and decriminalization to pharmaceutical advances and public company milestones.
Announcing the Psychedelics Law Blog!
Harris Sliwoski is pleased to announce the Psychedelics Law Blog! The Psychedelics Law Blog is a forum for discussing and analyzing the impact of psychedelics laws and reform on industry stakeholders, including health care operators, entrepreneurs, investors, regulators, advocates and others. On this new blog, we will continue to cover the psychedelics law and policy issues
Psychedelic Retreats: Organizer Legal Issues
Psychedelic retreats are all the rage (and that’s not a new thing), which causes a variety of organizer legal issues and a corresponding spectrum of liabilities. At Wonderland Miami, Horizons NYC, and on a regular basis outside of conferences, we are asked about legal advice for the organizers of psychedelic retreats. Both recreational and therapeutic
DMT Therapy: Coming to a Clinic Near You?
DMT, or N, N-dimethyltryptamine is a powerful psychedelic. DMT, like its sister psychedelics (LSD, MDMA, psilocybin … and even marijuana), is a Schedule I controlled substance. So according to the DEA, its abuse potential is high and it has no medical use. Also, according to the DEA, “the history of human experience probably goes back
I’m a Psychedelics Lawyer, Ask Me Anything
We are excited to announce that Harris Sliwoski attorney, Vince Sliwoski, will be hosting a Reddit Ask Me Anything (AMA) on Tuesday, November 30th at 4pm EST / 1pm PST to discuss psychedelics. View the conversation HERE. And make sure you submit your questions during the session! If you can’t wait for the AMA, you
Despite Initial Setback, Florida Lawmakers Remain Intent on Psychedelics Reform
In April of this year, Florida’s first attempt at psychedelics reform failed, as a House subcommittee rejected HB 549. This bill, introduced by Rep. Michael Grieco (D-Miami Beach), would have legalized the use of psilocybin for mental treatment in the nation’s third most populous state. Despite this setback, 2021 could yet be a pivotal year
Ketamine Clinic Acquisitions: Get the Law Right BEFORE the LOI
We often receive calls from potential ketamine clinic clients that just signed a letter of intent (“LOI”) or term sheet to acquire entire medical practices that are undertaking ketamine treatments. In the psychedelics space, many companies are starting off with off-label ketamine treatments while building towards a bigger suite of psychedelic services as the laws
Here’s How MDMA Will be Regulated
Cannabis is legal and regulated in most U.S. states. Oregon legalized and will soon regulate psilocybin. Cities around the country decriminalized (and more are decriminalizing) a host of other psychedelics. Ketamine clinics are popping up around the county. Next up is MDMA (referred to in some forms as “ecstasy”). Today, we’re going to talk about
Trademarking Psychedelics
Can companies in the psychedelic space register their trademarks, for psychedelics themselves? This is a question that often comes up, given U.S. trademark law’s requirement that marks be lawfully used in commerce as a precondition to registration. In recent times, many trademark applications filed by cannabis businesses have been refused on lawful-use grounds, though this
Is Psilocybin Really a Miracle Drug? Compass Pathways Releases Phase 2B Trial Results
Something strange happened yesterday. Psychedelics unicorn Compass Pathways released data for the largest clinical trial ever conducted of a psilocybin drug. Not only did the drug seem to work, but the heavily anticipated data were “breathtaking” in the words of Compass’ CEO. Immediately, the company’s publicly traded shares dropped 16%. Including the day prior, it